Mr. Pratap Sandhu reports

THE PRECISION PEPTIDE COMPANY OPENS NATIONWIDE RETAIL SALES DAYS AFTER FDA PANEL BACKS SIX OF SEVEN PEPTIDES UNDER REVIEW

Seven products of The Precision Peptide Company Inc. are in stock and available for direct purchase at the company's website across all 50 U.S. states.

The announcement follows the company's recently launched retail and telehealth platform and marks the point at which that platform begins transacting. It comes days after the U.S. Food and Drug Administration's pharmacy compounding advisory committee voted in favour of six of the seven peptides it reviewed, four of which are used in the company's existing formulations.

Products now available

Seven products are listed in stock across capsules, a topical serum and a transdermal patch.

The recovery patch is a transdermal peptide patch formulated for active individuals and is the company's first patch product available at retail. It is applied directly to the skin and requires no mixing, no measurement and no refrigeration. Additional patch formats remain in development.

BPC capsules are formulated to support recovery processes. KPV capsules are formulated for daily support of gut comfort, inflammatory response and skin appearance. Ageless capsules are formulated to support the body's repair and energy systems with aging. Chill capsules are formulated to support calm and restful sleep without melatonin. Blue capsules provide cellular energy support mental clarity and focus without caffeine. Hair is a copper-peptide serum formulated for scalp condition and the appearance of fuller hair.

Products are manufactured to current good manufacturing practice standards and third party tested for purity, potency and identity.

Alongside direct consumer sales, the company is accepting wholesale applications from clinics, gyms, spas and wellness retailers through the form at the Amino Innovations website. The company intends to provide a further update on that channel in due course.

Certification and infrastructure

The platform is supported by the previously announced LegitScript health care merchant certification. The certification independently supports compliance and consumer safety standards, and positions the company to process payments and conduct marketing activities across major payment and advertising platforms.

The retail catalogue operates alongside the U.S. compounding and telehealth infrastructure announced earlier this year, including the company's 503A compounding agreement and telehealth platform. GLP-1, Sermorelin and NAD+ protocols are listed on the platform as coming soon and would be delivered through that prescription pathway. No timeline for their availability has been established.

Pratap Sandhu, chief executive officer of The Precision Peptide Company, commented: "Our products are in stock and shipping to consumers in all 50 states. The platform we spent this year building is now transacting.

"The recovery patch is the product I would point to first. Putting a stable, needle-free peptide format in front of an everyday consumer is the reason this company exists, and it is now something people can buy."

FDA advisory committee vote

On July 23 and 24, 2026, the FDA's pharmacy compounding advisory committee reviewed seven peptides and voted in favour of six for consideration on the 503A bulks list. BPC-157, KPV, thymosin beta-4 and MOTS-c were supported on the first day, and semax and epitalon on the second. One substance was not recommended.

Four of the six supported peptides are used in formulations within the company's existing portfolio.

An advisory committee recommendation is not FDA approval. The votes are non-binding, the FDA is not required to follow them and any addition to the 503A bulks, list requires a separate formal rule-making process with an uncertain outcome and timeline. The 503A bulks list governs pharmacy compounding and does not apply to the over-the-counter products the company sells at retail.

About The Precision Peptide Company Inc.

Precision Peptide is a publicly traded wellness company building a next-generation platform for high-quality peptide formulations. By combining scientific formulation and innovative delivery technologies, the company creates products at the intersection of biotechnology and scalable consumer wellness. Products are manufactured in an approved U.S. facility and distributed across North America.

We seek Safe Harbor.